Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Finished Dosage Form (FDF) Manufacturing – Oral Solids

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract involves the manufacturing of finished dosage forms (FDF) specifically focused on oral solid oncology drugs. The scope includes the formulation, blending, compression, and coating of these drugs into tablets or capsules, followed by packaging into either clinical or commercial units. The work is subcontracted and falls under the NAICS code 325412, which covers pharmaceutical preparation manufacturing. The contract is issued by the Department of Veterans Affairs under the Nac Federal Supply Schedule (36F797). While specific details about the place of performance, set-aside type, or point of contact are not provided, the key functional focus remains on producing oral solid dosage forms for oncology indications, ensuring the supply of both clinical trial materials and commercial drug products.

General Info

Manufacturing oral solid oncology drugs tablets/capsules; formulation, packaging for clinical and commercial use.

Agency

Department Of Veterans Affairs → Nac Federal Supply Schedule (36F797)

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Federal Supply Schedule (36F797)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Veterans Affairs → Nac Federal Supply Schedule (36F797)
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Formulation, blending, compression, and coating of oncology drugs into tablets or capsules, including packaging into clinical or commercial units.

Similar Contracts

NAICS: 325412
New
Federal
6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 21 days
View Details